RankAlpha logo
Back to Rankings

HCM

HUTCHMED (China)D
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
HCM vs peer average
30/100
HCM vs. peer average (D vs. C)
Grade spread
A 3 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RXRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.42B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRXRXRecursion
HCM
HUTCHMED (China)
RXRX
Recursion
Grade
D
D
Momentum
36
93
Value
51
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs RXRX

HCM / RXRX
Grade Position
Below peers
HCM vs. peer average (D vs. C)
30/100
Momentum
36
RXRX
Value
51
HCM
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HCM
1
RXRX
Recursion Pharmaceuticals Inc Class A Common
D
40/100
Even
2
SUPN
Supernus Pharmaceuticals Inc Common
C
60/100
+1
3
NAMS
NewAmsterdam Pharma Company NV Common
F
20/100
-1
4
CLDX
Celldex Therapeutics Inc Common
C
60/100
+1
5
SLS
SELLAS Life Sciences Group Inc Common
A
100/100
+3
RXRX is the first peer returned for this comparison set.